Neo Ivy Capital Management’s Hologic HOLX Stock Holding History

Neo Ivy Capital Management’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,979	Closed	-$150K	–	420
2026 Q1	$150K	Buy	+1,979	New	+$149K	0.04%	279
2025 Q2	–	Sell	-12,740	Closed	-$787K	–	411
2025 Q1	$787K	Buy	+12,740	New	+$844K	0.25%	131
2023 Q4	–	Sell	-124	Closed	-$9K	–	358
2023 Q3	$9K	Buy	+124	New	+$9.37K	﹤0.01%	300
2022 Q4	$241K	Buy	+3,222	New	+$229K	0.16%	211
2022 Q3	–	Sell	-821	Closed	-$56K	–	449
2022 Q2	$56K	Buy	+821	New	+$60.9K	0.15%	219
2021 Q1	–	Sell	-4,810	Closed	-$350K	–	540
2020 Q4	$350K	Buy	+4,810	New	+$340K	0.39%	87
2020 Q1	–	Sell	-74	Closed	-$4K	–	494
2019 Q4	$4K	Sell	74 -11,557	-99%	-$575K	﹤0.01%	241
2019 Q3	$574K	Sell	11,631 -11,224	-49%	-$552K	0.38%	138
2019 Q2	$1.1M	Buy	+22,855	New	+$1.06M	0.62%	65

Other funds holding HOLX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Neo Ivy Capital Management's HOLX Position: Q2 2026 in Review

Neo Ivy Capital Management sold out of Hologic (HOLX) in Q2 2026, closing a stake of 1,979 shares — an estimated $150K sold.

Neo Ivy Capital Management first reported a position in HOLX in Q2 2019 and held it in 9 quarters. The position peaked at $1.1M in Q2 2019. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

Neo Ivy Capital Management reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
Neo Ivy Capital Management sold 1,979 Hologic shares in Q2 2026, an estimated $150K.
Neo Ivy Capital Management first reported a position in Hologic in Q2 2019 and held it in 9 quarters.
Neo Ivy Capital Management's Hologic position peaked at $1.1M in Q2 2019.
3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Neo Ivy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.